CDC: 1 in 45 Children Diagnosed With Autism
A total of 2.24% of U.S. children (1 in 45 children) aged 3 to 17 years have autism spectrum disorder (ASD), according to new statistics released by the 2014 National Health Interview Survey. The new figure is up from 1.25% reported from 2011 to 2013. The prevalence of developmental delay fell to 3.57% from 4.84%, while the rate of intellectual disability remained virtually…
The Toxic Logic of Water and Applesauce
Helmut R. R. Wakeham, PhD (chemistry) was chief scientist and director of research and development at Philip Morris tobacco company in the 1970s. In 1976, he was interviewed on television by British journalist Peter Taylor of the BBC and asked about the dangers of cigarette smoking, specifically about the harmfulness of the ingredients in cigarettes. In that particular exchange, Dr. Wakeham stated, “None of the things that have been found in tobacco smoke are in concentrations which can be considered harmful.”
Combating Vaccine Extremism in America | Barbara Loe Fisher
Toxic Exposure and Its Impact on American Students’ Cognitive Abilities
Over the last few years, there have been several news stories reporting that American students rank in the middle of the pack on cross-national tests, particularly in mathematics and science. The largest cross-national test, the OECD’s Programme for International Student Assessment (PISA), is a triennial survey evaluating education systems on a global level through…
Double Checking Sources: A Hallmark of Good Journalism
The evidence shows that the 2014-2015 influenza vaccine was an unmitigated failure. The Centers for Disease Control and Prevention (CDC) itself admitted that last year there had been considerable “drift” in the influenza strain most commonly in circulation: The A (H3N2) type unexpectedly predominant had not been predicted by those who were deciding on which…
European Agency Declares HPV Vaccines Safe, But Denmark, Japan Skeptical
A handful of countries, like Denmark and Japan, remain skeptical about human papillomavirus (HPV) vaccines, even though the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee’s (PRAC) safety review in 2015 did not change the agency’s position that the benefits of HPV vaccinations outweigh the risks. In July 2015, the PRAC in Europe launched a probe to investigate the safety of the three HPV vaccines available both in the United States and to countries in the European Union—Merck and Co.’s Gardasil and Gardasil 9 and GlaxoSmithKline’s Cervarix. Continuing reports of several HPV-related adverse events prompted the investigation.